Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
25%
OVERLAP
BY WEIGHT
30
# OF OVERLAPPING
HOLDINGS
FTXH
50
HOLDINGS
61%
ALSO IN XBI
XBI
138
HOLDINGS
22%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus XBI)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in XBI |
Overlap | |
|---|---|---|---|---|
 |
ALKERMES PLC | 1.3% | 1.2% | 1.2% |
 |
HALOZYME THERAPEUTICS INC | 1.3% | 1.2% | 1.2% |
|
ABBVIE INC | 7.5% | 1.1% | 1.1% |
|
INCYTE CORP | 2.4% | 1.1% | 1.1% |
|
AMGEN INC | 3.3% | 1.1% | 1.1% |
FTXH Overweight Relative to XBI
|
ELI LILLY & CO | 7.6% |
|
JOHNSON & JOHNSON | 7.1% |
|
MERCK & CO. INC. | 7.1% |
|
BRISTOL-MYERS SQUIBB CO | 6.7% |
|
ABBVIE INC | 6.4% |
|
VIATRIS, INC. | 3.9% |
|
CARDINAL HEALTH INC | 3.4% |
|
PFIZER INC | 3.0% |
|
JAZZ PHARMACEUTICALS PLC | 2.6% |
|
BIOGEN IDEC INC | 2.5% |
FTXH Underweight Relative to XBI
|
APOGEE THERAPEUTICS, INC. | -1.6% |
|
ORUKA THERAPEUTICS INC | -1.4% |
|
ERASCA, INC. | -1.4% |
|
DIANTHUS THERAPEUTICS INC | -1.3% |
|
REVOLUTION MEDICINES, INC. | -1.3% |
|
COGENT BIOSCIENCES INC | -1.3% |
|
CG ONCOLOGY, INC. | -1.3% |
|
VIKING THERAPEUTICS, INC. | -1.2% |
|
BRIDGEBIO PHARMA, INC. | -1.2% |
|
NATERA INC | -1.2% |